These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 1942057)
21. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site. Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354 [TBL] [Abstract][Full Text] [Related]
22. Crystallographic structure of human gamma-thrombin. Rydel TJ; Yin M; Padmanabhan KP; Blankenship DT; Cardin AD; Correa PE; Fenton JW; Tulinsky A J Biol Chem; 1994 Sep; 269(35):22000-6. PubMed ID: 8071320 [TBL] [Abstract][Full Text] [Related]
23. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide. Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin. Ganesh V; Lee AY; Clardy J; Tulinsky A Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754 [TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics simulations of thrombin inhibitors at the S' subsites of thrombin. Yue SY; Konishi Y Drug Des Discov; 1994 Jul; 12(1):1-17. PubMed ID: 7578804 [TBL] [Abstract][Full Text] [Related]
26. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site. Liu LW; Ye J; Johnson AE; Esmon CT J Biol Chem; 1991 Dec; 266(35):23633-6. PubMed ID: 1748641 [TBL] [Abstract][Full Text] [Related]
28. Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin. Tabernero L; Chang CY; Ohringer SL; Lau WF; Iwanowicz EJ; Han WC; Wang TC; Seiler SM; Roberts DG; Sack JS J Mol Biol; 1995 Feb; 246(1):14-20. PubMed ID: 7853394 [TBL] [Abstract][Full Text] [Related]
29. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures. Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407 [TBL] [Abstract][Full Text] [Related]
30. Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex. De Simone G; Lombardi A; Galdiero S; Nastri F; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V Protein Sci; 1998 Feb; 7(2):243-53. PubMed ID: 9521099 [TBL] [Abstract][Full Text] [Related]
31. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity. Ye J; Liu LW; Esmon CT; Johnson AE J Biol Chem; 1992 Jun; 267(16):11023-8. PubMed ID: 1317850 [TBL] [Abstract][Full Text] [Related]
32. Structures of thrombin retro-inhibited with SEL2711 and SEL2770 as they relate to factor Xa binding. Mochalkin I; Tulinsky A Acta Crystallogr D Biol Crystallogr; 1999 Apr; 55(Pt 4):785-93. PubMed ID: 10089309 [TBL] [Abstract][Full Text] [Related]
33. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors. Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244 [TBL] [Abstract][Full Text] [Related]
35. Crystal structure of a pyrimidine dimer-specific excision repair enzyme from bacteriophage T4: refinement at 1.45 A and X-ray analysis of the three active site mutants. Morikawa K; Ariyoshi M; Vassylyev DG; Matsumoto O; Katayanagi K; Ohtsuka E J Mol Biol; 1995 Jun; 249(2):360-75. PubMed ID: 7783199 [TBL] [Abstract][Full Text] [Related]
36. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein. Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170 [TBL] [Abstract][Full Text] [Related]
37. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity. Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257 [TBL] [Abstract][Full Text] [Related]
38. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Bode W; Turk D; Karshikov A Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349 [TBL] [Abstract][Full Text] [Related]
39. Rational design of true hirudin mimetics: synthesis and characterization of multisite-directed alpha-thrombin inhibitors. Lombardi A; Nastri F; Della Morte R; Rossi A; De Rosa A; Staiano N; Pedone C; Pavone V J Med Chem; 1996 May; 39(10):2008-17. PubMed ID: 8642559 [TBL] [Abstract][Full Text] [Related]
40. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution. Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]